Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation "TripleAXEL"


Phase 2 Results N/A

Summary of Purpose

Rationale Acute ischemic stroke due to atrial fibrillation (AF) carries a high risk for early recurrence. In acute stage, guidelines recommend aspirin, but do not recommend anticoagulation due to the increased risk of intracranial bleeding. Since, aspirin has a limited efficacy of preventing recurrent stroke in AF, expert consensus suggests early anticoagulation in non-severe stroke with AF. The current practice...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 July 2016.

1 Jan 2014 17 Jan 2014 1 Dec 2015 1 Dec 2015 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment